Beauty Health Co
For the period ended Dec 31, 2023. Filed Mar 12, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 12, 2024
SKIN$16.77+6.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, 2023 | December 31, 2022 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $523,025 | $568,197 |
| Accounts receivable, net of allowances for estimated credit losses of $6,604 and $2,929 at December 31, 2023 and December 31, 2022, respectively | 54,697 | 76,494 |
| Inventories | 91,321 | 109,656 |
| Income tax receivable | 332 | 1,280 |
| Prepaid expenses and other current assets | 28,877 | 27,648 |
| Total current assets | 698,252 | 783,275 |
| Property and equipment, net | 14,226 | 18,184 |
| Right-of-use assets, net | 12,120 | 15,637 |
| Intangible assets, net | 62,123 | 46,386 |
| Goodwill | 125,818 | 124,593 |
| Deferred income tax assets, net | 531 | 815 |
| Other assets | 16,043 | 14,193 |
| TOTAL ASSETS | $929,113 | $1,003,083 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $44,768 | $28,467 |
| Accrued payroll-related expenses | 22,028 | 21,677 |
| Syndeo Program reserves | 21,009 | — |
| Lease liabilities, current | 4,598 | 4,958 |
| Income tax payable | 2,759 | 1,429 |
| Other accrued expenses | 19,846 | 15,183 |
| Total current liabilities | 115,008 | 71,714 |
| Lease liabilities, non-current | 9,319 | 12,689 |
| Deferred income tax liabilities, net | 702 | 2,011 |
| Warrant liabilities | 3,555 | 15,473 |
| Convertible senior notes, net | 738,372 | 734,143 |
| Other long-term liabilities | 2,767 | — |
| Total liabilities | 869,723 | 836,030 |
| Commitments (Note 14) | ||
| Stockholders’ equity: | ||
| Class A Common Stock, $0.0001 par value; 320,000,000 shares authorized; 122,899,002 and 132,214,695 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 12 | 14 |
| Additional paid-in capital | 541,281 | 550,320 |
| Accumulated other comprehensive loss | (3,036) | (4,530) |
| Accumulated deficit | (478,867) | (378,751) |
| Total stockholders’ equity | 59,390 | 167,053 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $929,113 | $1,003,083 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.